Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Actinogen Medical Ltd (ACW)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.030 +0.001    +1.72%
14:47:13 - Delayed Data. Currency in AUD ( Disclaimer )
  • Volume: 444,153
  • Bid/Ask: 0.029 / 0.030
  • Day's Range: 0.029 - 0.030
Type:  Equity
Market:  Australia
ISIN:  AU000000ACW3 
Actinogen Medical 0.030 +0.001 +1.72%

Actinogen Medical Ltd Company Profile

 
Get an in-depth profile of Actinogen Medical Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

6

Equity Type

ORD

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, depression with cognitive impairment, Alzheimer’s disease, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Contact Information

Address 109 Pitt Street Suite 901
Level 9 Sydney, 2000
Australia
Phone 61 2 8964 7401
Fax 61 2 8964 7588

Top Executives

Name Age Since Title
Steven G. Gourlay 62 2021 MD, CEO & Director
Alan Keith Boyd 66 - Member of Scientific Advisory Board
Geoffrey Edward Duncan Brooke 65 2017 Independent Non-Executive Chairman
Christina Kurre Olsen - 2022 Member of Depression & Cognition Clinical Advisory Board
Christopher Chen - 2022 Member of Depression & Cognition Clinical Advisory Board
Jeffrey L. Cummings 73 2015 Member of Xanamem Clinical Advisory Board
Jonathan Seckl - - Member of Scientific Advisory Board
Malcolm John McComas 68 2019 Independent Non-Executive Director
Brian R. Walker - - Member of Scientific Advisory Board
Craig W. Ritchie - 2015 Chairman of Xanamem Clinical Advisory Board
Colin Louis Masters 76 2015 Member of Xanamem Clinical Advisory Board
George Morstyn 73 2017 Independent Non-Executive Director
Scott Webster - - Member of Scientific Advisory Board
John Harrison - 2022 Member of Depression & Cognition Clinical Advisory Board
Nicki Vasquez 59 2023 Independent Non-Executive Director
Dana C. Hilt 70 2022 Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ACW Comments

Write your thoughts about Actinogen Medical Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Chris Smith
Chris Smith Nov 19, 2019 16:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will it keep going?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email